Sponsor:
Autoimmune Neurology Alliance
Code:
NCT07761026
Conditions
Myasthenia Gravis (MG)
Myasthenia Gravis, Generalized
Myasthenia Gravis, Ocular
Myasthenia Gravis Crisis
Myasthenia Gravis Associated With Thymoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Myasthenia Gravis (MG)
Myasthenia Gravis, Generalized
Myasthenia Gravis, Ocular
Myasthenia Gravis Crisis
Myasthenia Gravis Associated With Thymoma
Study ID
NCT07761026
Start date
Mar 19, 2026
Status verified date
Aug, 2026
Completion date
Mar, 2036
Anticipated
Primary completion date
Mar, 2036
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
1000 participants
Anticipated
Arms
Myasthenia Gravis (MG)
Primary outcome measure
Central contacts
President, Board of Directors, Autoimmune Neurology Alliance
info@ainalliance.orgLocations
Alira Health - Virtual/Remote Site - Can Be Completed 100% Online - All US Residents Accepted
Recruiting
Framingham, Massachusetts, United States, 01702
Contacts
President, Board of Directors, Autoimmune Neurology Alliance
info@ainalliance.orgPrincipal Investigator:
Jared R Adams, MD, PhD
Sponsor
Autoimmune Neurology Alliance
Last update posted
Aug 17, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Autoimmune Neurology Alliance on 2026-08-17.